Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Acorda Therapeutics USD 25.27M 4.98M 2023-06
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amarin USD 270.81M 37.82M 2023-09
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Biogen USD 1.05B 1.24B 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Enanta Pharmaceuticals USD 85.39M 9.79M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Galectin Therapeutics USD 20.36M 2.4M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Moderna USD 2.91B 25M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Intercept Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.